According to research, Gilead’s long-acting HIV medication is superior to Truvada

June 21, 2024

Concerns Grow Over Safety of BioGen’s Aduhelm after Death of More Patient Who Got the Drug

February 23, 2022

AMAP by Charles River to work towards developing alternatives to animal testing

April 29, 2024

Must Read

U.S. Biopharma Companies Advance Over $370B in Manufacturing and R&D Investments

December 4, 2025

Bristol Myers Postpones Important Alzheimer’s Psychosis Cobenfy Readout

December 4, 2025

Triana Biomedicines Secures $120 Million Series B to Advance Lead Molecular Glue Degrader

December 4, 2025

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Editor Picks

According to research, Gilead’s long-acting HIV medication is superior to Truvada

Concerns Grow Over Safety of BioGen’s Aduhelm after Death of More Patient Who Got the Drug

AMAP by Charles River to work towards developing alternatives to animal testing

Must Read

U.S. Biopharma Companies Advance Over $370B in Manufacturing and R&D Investments

Bristol Myers Postpones Important Alzheimer’s Psychosis Cobenfy Readout

Triana Biomedicines Secures $120 Million Series B to Advance Lead Molecular Glue Degrader

Hot Topics

About Us

Follow Us